Lactoferrin: Antimicrobial and diagnostic properties

Biotecnologia Aplicada

Volumn 18, Issue 2, 2001, Pages 76-83

  Lao, A A ^a   Brock, J H ^a  

^a FINLAY INSTITUTE   (Cuba)

Author keywords

Antibacterial agents; Antiviral agents; Endotoxemia; Immunomodulation; Inflammation; Iron; Lactoferrin

Indexed keywords

LACTOFERRIN; RECOMBINANT PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTHRITIS; AUTOIMMUNITY; BACTERIAL INFECTION; BREAST FEEDING; BREAST MILK; CELLULAR IMMUNITY; DIAGNOSTIC VALUE; DIGESTIVE SYSTEM INFLAMMATION; ENDOTOXEMIA; HEPATITIS C; IMMUNE SYSTEM; IMMUNOMODULATION; NONHUMAN; REVIEW; SEPSIS;

BACTERIA (MICROORGANISMS); HEPATITIS C VIRUS;

EID: 0035038555     PISSN: 08644551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Immunobiology and epidemiology of breastfeeding in relation to prevention of infections from a global perspective
2. Efficacy and pharmacokinetics of intravenous immune globulin administration to high-risk neonates
3. Immunologic factors in human milk during the first year of lactation
4. Iron and transferrin. Research and therapeutic applications
5. Extracellular iron reductases: Identification of a new class of enzymes by siderophore-producing microorganisms
6. Isolation and structure-functional characterization of human colostral lactoferrin
7. A system for production of commercial quantities of human lactoferrin: A broad spectrum natural antibiotic
8. The iron-uptake systems of pathogenic bacteria, fungi and protozoa
9. The therapeutic effect of bovine lactoferrin in the host infected with Helicobacter pylori
10. Lactoferrin can supply iron for the growth of Bifidabacterium breve
11. The effects of Lactoferrin on Gram-negative bacteria
12. Porins Ompc and PhoE of Escherichia coli as specific cell-surface targets of human lactoferrin: Binding characteristics and biological effects
13. Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae
14. Release of iron from phagocytosed Escherichia coli and uptake by neutrophil lactoferrin
15. Rapid membrane permeabilization and inhibition of vital functions of Gram-negative bacteria by bactenecins
16. Identification of an active domain of bovine lactoferrin that enhances the phagocytic activity of human neutrophils
17. 5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA
18. Inhibition of growth of Staphylocaccus aureus is a function of its iron-binding properties
19. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein
20. Lactoferrin inhibits the binding of lipopolysaccharide to L-selectin and subsequent production of reactive oxygen species by neutrophils
21. Direct evidence of the generation in the human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin
22. The effects of local administration of lactoferrin on inflammation in murine autoimmune and infectious arthritis
23. Influence of lactoferrin feeding and injection against systemic staphylococcal infection in mice
24. The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets
25. Glycatian ligon binding motif in lactoferrin: Implications in diabetic infection
26. Human loctoferrin: Production at large scale, characterization and applications
27. Antivirol activity in milk of possible clinical importance
28. Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection
29. Antiviral effects of plasma and milk proteins: Lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro
30. Metal complexes of bovine lactoferrin inhibit in vitro replication of herpes simplex virus type 1 and type 2
31. Antirotaviral activity of milk proteins: Lactoferrin prevents rotavirus infection in the enterocyte like cell line HT-29
32. Inhibition of poliovirus type 1 infection by iron, manganese and zinc saturated lactoferrin
33. Characterization of antiviral activity of lactoferrin against Hepatitis C virus infection in human cultured cells
34. Characterization of the glycosaminoglycan-binding region of lactoferrin
35. Hepatitis C virus envelope proteins bind lactoferrin
36. Antiviral effects of milk proteins: Acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro
37. Antiviral activity of lactoferrin-derived peptides
38. Glycosylated and unglycosylated human lactoferrin both bind iron and show identical affinities towards human lysozyme and bacterial lipopolysaccharide, but differ in their susceptibility towards tryptic proteolysis
39. Impairment of circulating lactoferrin in HIV-infection
40. Lactoferrin inhibits herpes simplex virus type - 1 (HSV-1) infection to mouse cornea
41. Lactoferrin-mediated protection of the host from murine cytomegalovirus infection by a T-cell-dependent augmentation of natural killer cell activity
42. Synergistic effect of human lactoferrin and recombinant murine interferon-gamma on disease progression in mice infected with the polycythemia-inducing strain of the Friend virus complex
43. Lactoferrin inhibits Hepatitis C virus viremia in patients with chronic Hepatitis C: A pilot study
44. Therapy of Hepatitis C: Other options
45. Lactoferrin inhibits HIV-1 replication in vitro and exhibits synergy when combined with zidovudine
46. On the differential diagnosis of the dysenteries. The diagnostic value of the cell-exudate in the stools of acute and bacillary disentery
47. Fecal leukocytes in diarrheal illness
48. To culture or not to culture: Fecal lactoferrin screening for inflammatory bacterial diarrhea
49. Fecal screening tests in the approach to acute infectious diarrhea: A scientific overview
50. Utility of a rapid fecal latex agglutination test detecting the neutrophil, lactoferrin, for diagnosis inflammatory causes of chronic diarrhea
51. Accuracy of fecal lactoferrin and other stool tests for diagnosis of invasive diarrhea at a Colombian pediatric hospital
52. Role of basic residues of human lactoferrin in the interaction with B lymphocytes
53. Activated human gd-T lymphocytes express functional lactoferrin receptors
54. The binding of lactoferrin to mouse peritoneal cells
55. Receptor binding of lactoferrin by human monocytes
56. Inhibition of binding of lactoferrin to the human promonocyte cell line THP-1 by heparin: The role of cell surface sulphated molecules
57. Expression of human lactotransferrin receptors in phytohaemagglutinin-stimulated human peripheral blood lymphocytes: Isolation of the receptors by antiligand affinity chromotography
58. Effects of human lactoferrin in NK cell cytotoxicity against haematopoietic and epithelial tumour cells
59. Binding of lactoferrin and transferrin to the human promonocytic cell line U937. Effect on iron uptake and release
60. Lactoferrin derived from human neutrophils inhibits the mixed lymphocyte reaction
61. Immunomodulatory effect of bovine lactoferrin pepsin hydrolysate an murine splenocytes and Peyer's patch cells
62. Activation of macrophages by lactoferrin: Secretion of TNF-alpha, IL-8 and NO
63. Lactoferrin, anti-lactoferrin autoantibodies and inflammatory disease
64. Leucocyte activation by anti-lactoferrin antibodies bound to vascular endothelium
65. Anti-inflammatory and immunoregulatory effects of lactoferrin
66. Human milk proteins including secretory IgA fail to elicit tolerance after feeding